Inflammation and Neuro-Immune Dysregulations in Autism Spectrum Disorders

American Psychiatric Association (2013). Diagnostic and Statistical Manual of Mental Disorders, American Psychiatric Publishing. Autism Spectrum Disorder.

Onore, 2012, The role of immune dysfunction in the pathophysiology of autism, Brain Behav. Immun., 26, 383, 10.1016/j.bbi.2011.08.007

Xu, 2015, Inflammatory cytokines: Potential biomarkers of immunologic dysfunction in autism spectrum disorders, Med. Inflamm., 2015, 531518, 10.1155/2015/531518

Siniscalco, 2013, Therapeutic role of hematopoietic stem cells in autism spectrum disorder-related inflammation, Front. Immunol., 4, 140, 10.3389/fimmu.2013.00140

Siniscalco, 2013, Epigenetic findings in autism: New perspectives for therapy, Int. J. Environ. Res. Public Health, 10, 4261, 10.3390/ijerph10094261

Zhubi, 2017, Epigenetic regulation of RELN and GAD1 in the frontal cortex (FC) of autism spectrum disorder (ASD) subjects, Int. J. Dev. Neurosci., 62, 63, 10.1016/j.ijdevneu.2017.02.003

Hansen, 2014, Common DNA methylation alterations in multiple brain regions in autism, Mol. Psychiatry, 19, 862, 10.1038/mp.2013.114

Pu, 2013, Association between MTHFR gene polymorphisms and the risk of autism spectrum disorders: A meta-analysis, Autism Res., 6, 384, 10.1002/aur.1300

Sun, 2016, Histone Acetylome-wide Association Study of Autism Spectrum Disorder, Cell, 167, 1385, 10.1016/j.cell.2016.10.031

Wu, 2016, Genome-wide, integrative analysis implicates microRNA dysregulation in autism spectrum disorder, Nat. Neurosci., 19, 1463, 10.1038/nn.4373

Croonenberghs, 2002, Activation of the inflammatory response system in autism, Neuropsychobiology, 45, 1, 10.1159/000048665

Brigida, A.L., Schultz, S., Cascone, M., Antonucci, N., and Siniscalco, D. (2017). Endocannabinod Signal Dysregulation in Autism Spectrum Disorders: A Correlation Link between Inflammatory State and Neuro-Immune Alterations. Int. J. Mol. Sci., 18.

Brocker, 2010, Evolutionary divergence and functions of the human interleukin (IL) gene family, Hum. Genom., 5, 30, 10.1186/1479-7364-5-1-30

Ashwood, 2011, Elevated plasma cytokines in autism spectrum disorders provide evidence of immune dysfunction and are associated with impaired behavioral outcome, Brain Behav. Immun., 25, 40, 10.1016/j.bbi.2010.08.003

Enstrom, 2010, Differential monocyte responses to TLR ligands in children with autism spectrum disorders, Brain Behav. Immun., 24, 64, 10.1016/j.bbi.2009.08.001

Molloy, 2006, Elevated cytokine levels in children with autism spectrum disorder, J. Neuroimmunol., 172, 98, 10.1016/j.jneuroim.2005.11.007

Inga Jácome, M.C., Morales Chacòn, L.M., Vera Cuesta, H., Maragoto Rizo, C., Whilby Santiesteban, M., Ramos Hernandez, L., Noris García, E., González Fraguela, M.E., Fernandez Verdecia, C.I., and Vegas Hurtado, Y. (2016). Peripheral Inflammatory Markers Contributing to Comorbidities in Autism. Behav. Sci., 6.

Xie, 2017, Immunological cytokine profiling identifies TNF-α as a key molecule dysregulated in autistic children, Oncotarget, 8, 82390, 10.18632/oncotarget.19326

Hu, C.C., Xu, X., Xiong, G.L., Xu, Q., Zhou, B.R., Li, C.Y., Qin, Q., Liu, C.X., Li, H.P., and Sun, Y.J. (2018). Alterations in plasma cytokine levels in Chinese children with autism spectrum disorder. Autism Res.

Eftekharian, 2018, Cytokine profile in autistic patients, Cytokine, 108, 120, 10.1016/j.cyto.2018.03.034

Guloksuz, 2017, Elevated plasma concentrations of S100 calcium-binding protein B and tumor necrosis factor alpha in children with autism spectrum disorders, Rev. Bras. Psiquiatr., 39, 195, 10.1590/1516-4446-2015-1843

2005, Pro-inflammatory cytokines in autistic children in central Saudi Arabia, Neurosciences (Riyadh), 10, 155

Suzuki, K., Matsuzaki, H., Iwata, K., Kameno, Y., Shimmura, C., Kawai, S., Yoshihara, Y., Wakuda, T., Takebayashi, K., and Takagai, S. (2011). Plasma cytokine profiles in subjects with high-functioning autism spectrum disorders. PLoS ONE, 6.

Croen, 2008, Maternal mid-pregnancy autoantibodies to fetal brain protein: The early markers for autism study, Biol. Psychiatry, 64, 583, 10.1016/j.biopsych.2008.05.006

Braunschweig, 2012, Maternal autoantibodies in autism, Arch. Neurol., 69, 693, 10.1001/archneurol.2011.2506

Braunschweig, 2008, Autism: Maternally derived antibodies specific for fetal brain proteins, Neurotoxicology, 29, 226

Goines, 2011, Autoantibodies to cerebellum in children with autism associate with behavior, Brain Behav. Immun., 25, 514, 10.1016/j.bbi.2010.11.017

Braunschweig, 2013, Autism-specific maternal autoantibodies recognize critical proteins in developing brain, Transl. Psychiatry, 3, e277, 10.1038/tp.2013.50

Meltzer, 2017, The Role of the Immune System in Autism Spectrum Disorder, Neuropsychopharmacology, 42, 284, 10.1038/npp.2016.158

Navarro, 2016, Can probiotics benefit children with autism spectrum disorders?, World J. Gastroenterol., 22, 10093, 10.3748/wjg.v22.i46.10093

Navarro, 2015, Are ‘leaky gut’ and behavior associated with gluten and dairy containing diet in children with autism spectrum disorders?, Nutr. Neurosci., 18, 177, 10.1179/1476830514Y.0000000110

Familiari, 2010, Alterations of the intestinal barrier in patients with autism spectrum disorders and in their first-degree relatives, J. Pediatr. Gastroenterol. Nutr., 51, 418, 10.1097/MPG.0b013e3181dcc4a5

Picardi, 2013, Antibodies against food antigens in patients with autistic spectrum disorders, Biomed. Res. Int., 2013, 729349

Fiorentino, 2016, Blood-brain barrier and intestinal epithelial barrier alterations in autism spectrum disorders, Mol. Autism, 7, 49, 10.1186/s13229-016-0110-z

Doenyas, 2018, Gut Microbiota, Inflammation, and Probiotics on Neural Development in Autism Spectrum Disorder, Neuroscience, 374, 271, 10.1016/j.neuroscience.2018.01.060

Iovene, 2017, Intestinal Dysbiosis and Yeast Isolation in Stool of Subjects with Autism Spectrum Disorders, Mycopathologia, 182, 349, 10.1007/s11046-016-0068-6

Finegold, 2002, Gastrointestinal microflora studies in late-onset autism, Clin. Infect. Dis., 35, S6, 10.1086/341914

Johnson, K.V., and Foster, K.R. (2018). Why does the microbiome affect behaviour?. Nat. Rev. Microbiol.

Cristiano, 2018, Interplay Between Peripheral and Central Inflammation in Autism Spectrum Disorders: Possible Nutritional and Therapeutic Strategies, Front. Physiol., 9, 184, 10.3389/fphys.2018.00184

Theoharides, 2013, Focal brain inflammation and autism, J. Neuroinflamm., 10, 46, 10.1186/1742-2094-10-46

Wei, 2013, Brain IL-6 and autism, Neuroscience, 252, 320, 10.1016/j.neuroscience.2013.08.025

Wei, 2012, Alteration of brain volume in IL-6 overexpressing mice related to autism, Int. J. Dev. Neurosci., 30, 554, 10.1016/j.ijdevneu.2012.08.007

Wei, 2012, Brain IL-6 elevation causes neuronal circuitry imbalances and mediates autism-like behaviors, Biochim. Biophys. Acta, 1822, 831, 10.1016/j.bbadis.2012.01.011

Vargas, 2005, Neuroglial activation and neuroinflammation in the brain of patients with autism, Ann. Neurol., 57, 67, 10.1002/ana.20315

Theoharides, 2016, Atopic diseases and inflammation of the brain in the pathogenesis of autism spectrum disorders, Transl. Psychiatry, 6, e844, 10.1038/tp.2016.77

2012, Neuroinflammation in autism spectrum disorders, J. Neuroinflamm., 9, 265

Alabdali, 2014, Association of social and cognitive impairment and biomarkers in autism spectrum disorders, J. Neuroinflamm., 11, 4, 10.1186/1742-2094-11-4

Prata, 2017, Bridging Autism Spectrum Disorders and Schizophrenia through inflammation and biomarkers—Pre-clinical and clinical investigations, J. Neuroinflamm., 14, 179, 10.1186/s12974-017-0938-y

Olszewski, 2007, TNF trafficking to human mast cell granules: Mature chain-dependent endocytosis, J. Immunol., 178, 5701, 10.4049/jimmunol.178.9.5701

Banerjee, 2012, Interleukin-1 (IL-1) family of cytokines: Role in type 2 diabetes, Clin. Chim. Acta, 413, 1163, 10.1016/j.cca.2012.03.021

Szalecki, 2018, Interactions between the growth hormone and cytokines—A review, Adv. Med. Sci., 63, 285, 10.1016/j.advms.2018.03.001

Jyonouchi, 2014, Cytokine profiles by peripheral blood monocytes are associated with changes in behavioral symptoms following immune insults in a subset of ASD subjects: An inflammatory subtype?, J. Neuroinflamm., 11, 187, 10.1186/s12974-014-0187-2

Jyonouchi, 2012, Immunological characterization and transcription profiling of peripheral blood (PB) monocytes in children with autism spectrum disorders (ASD) and specific polysaccharide antibody deficiency (SPAD): Case study, J. Neuroinflamm., 9, 4, 10.1186/1742-2094-9-4

Siniscalco, 2012, The expression of caspases is enhanced in peripheral blood mononuclear cells of autism spectrum disorder patients, J. Autism Dev. Disord., 42, 1403, 10.1007/s10803-011-1373-z

Siniscalco, 2008, Involvement of subtype 1 metabotropic glutamate receptors in apoptosis and caspase-7 over-expression in spinal cord of neuropathic rats, Pharmacol. Res., 57, 223, 10.1016/j.phrs.2008.01.007

Preedy, V., and Martin, C. (2014). Receptor/Regulatory Molecules Pattern Changes: Caspases in Autism Spectrum Disorders. Comprehensive Guide to Autism Patel, Springer.

Sordet, 2002, Specific involvement of caspases in the differentiation of monocytes into macrophages, Blood, 100, 4446, 10.1182/blood-2002-06-1778

Siniscalco, 2014, The in vitro GcMAF effects on endocannabinoid system transcriptionomics, receptor formation, and cell activity of autism-derived macrophages, J. Neuroinflamm., 11, 78, 10.1186/1742-2094-11-78

Siniscalco, 2013, Cannabinoid receptor type 2, but not type 1, is up-regulated in peripheral blood mononuclear cells of children affected by autistic disorders, J. Autism Dev. Disord., 43, 2686, 10.1007/s10803-013-1824-9

Nadeem, 2018, Activation of IL-17 receptor leads to increased oxidative inflammation in peripheral monocytes of autistic children, Brain Behav. Immun., 67, 335, 10.1016/j.bbi.2017.09.010

Siniscalco, 2015, Commentary: The Impact of Neuroimmune Alterations in Autism Spectrum Disorder, Front. Psychiatry, 6, 145, 10.3389/fpsyt.2015.00145

Theoharides, 2015, Dysregulated brain immunity and neurotrophin signaling in Rett syndrome and autism spectrum disorders, J. Neuroimmunol., 279, 33, 10.1016/j.jneuroim.2014.12.003

Theoharides, 2016, Mast cells, brain inflammation and autism, Eur. J. Pharmacol., 778, 96, 10.1016/j.ejphar.2015.03.086

Morgan, 2010, Microglial activation and increased microglial density observed in the dorsolateral prefrontal cortex in autism, Biol. Psychiatry, 68, 368, 10.1016/j.biopsych.2010.05.024

Tetreault, 2012, Microglia in the cerebral cortex in autism, J. Autism Dev. Disord., 42, 2569, 10.1007/s10803-012-1513-0

Gottfried, 2015, The Impact of Neuroimmune Alterations in Autism Spectrum Disorder, Front. Psychiatry, 6, 121, 10.3389/fpsyt.2015.00121

Perry, 2010, Microglia in neurodegenerative disease, Nat. Rev. Neurol., 6, 193, 10.1038/nrneurol.2010.17

Radtke, 2017, Modulating Neuroinflammation to Treat Neuropsychiatric Disorders, Biomed. Res. Int., 2017, 5071786, 10.1155/2017/5071786

Gupta, 2014, Transcriptome analysis reveals dysregulation of innate immune response genes and neuronal activity-dependent genes in autism, Nat. Commun., 5, 5748, 10.1038/ncomms6748

Voineagu, 2011, Transcriptomic analysis of autistic brain reveals convergent molecular pathology, Nature, 474, 380, 10.1038/nature10110

Kalkman, H.O., and Feuerbach, D. (2017). Microglia M2A Polarization as Potential Link between Food Allergy and Autism Spectrum Disorders. Pharmaceuticals, 10.

Zhang, 2017, IL-4/IL-13-mediated polarization of renal macrophages/dendritic cells to an M2a phenotype is essential for recovery from acute kidney injury, Kidney Int., 91, 375, 10.1016/j.kint.2016.08.020

Wendeln, A.C., Degenhardt, K., Kaurani, L., Gertig, M., Ulas, T., Jain, G., Wagner, J., Häsler, L.M., Wild, K., and Skodras, A. (2018). Innate immune memory in the brain shapes neurological disease hallmarks. Nature.

Cieślińska, A., Kostyra, E., Chwała, B., Moszyńska-Dumara, M., Fiedorowicz, E., Teodorowicz, M., Savelkoul, H.F.J., and Vitamin, D. (2017). Receptor Gene Polymorphisms Associated with Childhood Autism. Brain Sci., 7.

Warren, 1987, Reduced natural killer cell activity in autism, J. Am. Acad. Child. Adolesc. Psychiatry, 26, 333, 10.1097/00004583-198705000-00008

Yin, 2017, The Role of Microglia and Macrophages in CNS Homeostasis, Autoimmunity, and Cancer, J. Immunol. Res., 2017, 5150678, 10.1155/2017/5150678

Takano, 2015, Role of microglia in autism: Recent advances, Dev. Neurosci., 37, 195, 10.1159/000398791

Siniscalco, 2016, Decreased Numbers of CD57+CD3− Cells Identify Potential Innate Immune Differences in Patients with Autism Spectrum Disorder, In Vivo, 30, 83

Enstrom, 2009, Altered gene expression and function of peripheral blood natural killer cells in children with autism, Brain Behav. Immun., 23, 124, 10.1016/j.bbi.2008.08.001

Petrelli, 2018, mGlu5-mediated signalling in developing astrocyte and the pathogenesis of autism spectrum disorders, Curr. Opin. Neurobiol., 48, 139, 10.1016/j.conb.2017.12.014

Siniscalco, 2014, Adhesion G-protein Coupled Receptors in Autism, Autism-Open Access, 4, e126

Siniscalco, 2004, Blockade of glutamate mGlu5 receptors in a rat model of neuropathic pain prevents early over-expression of pro-apoptotic genes and morphological changes in dorsal horn lamina II, Neuropharmacology, 46, 468, 10.1016/j.neuropharm.2003.10.014

Palazzo, 2004, Metabotropic glutamate receptor 5 and dorsal raphe serotonin release in inflammatory pain in rat, Eur. J. Pharmacol., 492, 169, 10.1016/j.ejphar.2004.03.063

Vicidomini, 2017, Pharmacological enhancement of mGlu5 receptors rescues behavioral deficits in SHANK3 knock-out mice, Mol. Psychiatry, 22, 689, 10.1038/mp.2016.30

Bradstreet, 2014, A New Methodology of Viewing Extra-Axial Fluid and Cortical Abnormalities in Children with Autism via Transcranial Ultrasonography, Front. Hum. Neurosci., 7, 934, 10.3389/fnhum.2013.00934

Young, 2016, From molecules to neural morphology: Understanding neuroinflammation in autism spectrum condition, Mol. Autism, 7, 9, 10.1186/s13229-016-0068-x

Gallardo, 2016, Characterization of immune cell phenotypes in adults with autism spectrum disorders, J. Investig. Med., 64, 1179, 10.1136/jim-2016-000070

Ashwood, 2011, Altered T cell responses in children with autism, Brain Behav. Immun., 25, 840, 10.1016/j.bbi.2010.09.002

Bradstreet, 2014, Efficacy of fetal stem cell transplantation in autism spectrum disorders: An open-labeled pilot study, Cell Transplant., 23, S105, 10.3727/096368914X684916

Hsiao, 2012, Modeling an autism risk factor in mice leads to permanent immune dysregulation, Proc. Natl. Acad. Sci. USA, 109, 12776, 10.1073/pnas.1202556109

Lucchina, 2014, Altered peripheral and central inflammatory responses in a mouse model of autism, Autism Res., 7, 273, 10.1002/aur.1338

Codagnone, 2015, Differential Local Connectivity and Neuroinflammation Profiles in the Medial Prefrontal Cortex and Hippocampus in the Valproic Acid Rat Model of Autism, Dev. Neurosci., 37, 215, 10.1159/000375489

Gupta, 2010, Adaptive and Innate Immune Responses in Autism: Rationale for Therapeutic Use of Intravenous Immunoglobulin, J. Clin. Immunol., 30, S90, 10.1007/s10875-010-9402-9

Wong, 2016, Impact of Immunoglobulin Therapy in Pediatric Disease: A Review of Immune Mechanisms, Clin. Rev. Allergy Immunol., 51, 303, 10.1007/s12016-015-8499-2

Melamed, 2018, A pilot study of high-dose intravenous immunoglobulin 5% for autism: Impact on autism spectrum and markers of neuroinflammation, Autism Res., 11, 421, 10.1002/aur.1906

Gupta, 1996, Dysregulated immune system in children with autism: Beneficial effects of intravenous immune globulin on autistic characteristics, J. Autism Dev. Disord., 26, 439, 10.1007/BF02172828

Plioplys, 1998, Intravenous immunoglobulin treatment of children with autism, J. Child. Neurol., 13, 79, 10.1177/088307389801300207

Shenoy, 2000, Response to steroid therapy in autism secondary to autoimmune lymphoproliferative syndrome, J. Pediatr., 136, 682, 10.1067/mpd.2000.105355

Duffy, F.H., Shankardass, A., McAnulty, G.B., Eksioglu, Y.Z., Coulter, D., Rotenberg, A., and Als, H. (2014). Corticosteroid therapy in regressive autism: A retrospective study of effects on the Frequency Modulated Auditory Evoked Response (FMAER), language, and behavior. BMC Neurol., 14.

Ashwood, P., Corbett, B.A., Kantor, A., Schulman, H., Van de Water, J., and Amaral, D.G. (2011). In search of cellular immunophenotypes in the blood of children with autism. PLoS ONE, 6.

Rose, 2014, Potential cytokine biomarkers in autism spectrum disorders, Biomark. Med., 8, 1171, 10.2217/bmm.14.39

Masi, 2017, The Immune System, Cytokines, and Biomarkers in Autism Spectrum Disorder, Neurosci. Bull., 33, 194, 10.1007/s12264-017-0103-8

Bilbo, 2018, Beyond infection—Maternal immune activation by environmental factors, microglial development, and relevance for autism spectrum disorders, Exp. Neurol., 299, 241, 10.1016/j.expneurol.2017.07.002

Santocchi, E., Guiducci, L., Fulceri, F., Billeci, L., Buzzigoli, E., Apicella, F., Calderoni, S., Grossi, E., Morales, M.A., and Muratori, F. (2016). Gut to brain interaction in Autism Spectrum Disorders: A randomized controlled trial on the role of probiotics on clinical, biochemical and neurophysiological parameters. BMC Psychiatry, 16.

Liu, J., Liu, X., Xiong, X.Q., Yang, T., Cui, T., Hou, N.L., Lai, X., Liu, S., Guo, M., and Liang, X.H. (2017). Effect of vitamin A supplementation on gut microbiota in children with autism spectrum disorders—A pilot study. BMC Microbiol., 17.